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HEMAN airway preparations at resting tone were relaxed
with either the leukotriene synthesis inhibitorBAYx1005
(3 tM), chlorpheniramine (1 btM) or the thromboxane
receptor antagonist BAY u3405 (0.1 tM). The response to
anti-IgE (1:1000) was 58 + 8% of acetylcholine pre-con-
traction (2.19 + 0.28 g). Indomethacin (3 tM) enhanced
the anti-IgE-induced contraction by 28%. The anti-IgE
maximal response was not modified by either
chlorpheniramine, BAY x1005 or BAY u3405. When the
tissues were treated with either BAY xl005/indomethacin
or BAY x1005/chlorpheniramine, the anti-IgE-induced
contraction was reduced. In addition, in presence ofBAY
xl005/indomethacin/chlorpheniramine the response
was completelyblocked. These results suggest that media-
tots released during anti-IgE challenge cause airway con-
traction which may mask the evaluation of the
leukotriene component.
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Introduction
Challenge of airway smooth muscle in vitro with
an appropriate antigen provokes the release of a
variety of inflammatory mediators. 1-3 Data obtained
in guinea-pig respiratory tissues demonstrated the
release of histamine during the contraction induced
by antigen as well as metabolites of both the
cyclooxygenase and 5-1ipoxygenase pathways.4-7
Adams and Lichtenstein showed that human airways
when passively sensitized and challenged with
ragweed antigen, an initial histamine response fol-
lowed by a leukotriene (LT) component in the con-
traction could be observed. Undem et al. described
a potential role for products of the cyclooxygenase
pathway, specifically PGE2, in regulating histamine
release in human bronchial muscles preparations. In
addition, these investigators also demonstrated an
increased quantity of LTs in the presence of
indomethacin (Ind) when human airways were chal-
lenged with antigen. In contrast, other authors have
shown inhibitory, or no effects, of Ind on antigenic
challenge in human airways. 1-13 Recently, Bj/Srck and
DahMn14 have reported that potent LT antagonists
and/or 5-1ipoxygenase inhibitors decreased the anti-
IgE induced contractions. In other studies, such in-
hibition could be seen only in presence of addi-
tional inhibitors or antagonists. 15-17 This study was
undertaken in order to define the relative contribu-
tion of each inflammatory mediator implicated in
anti-IgE-induced contraction in human isolated bron-
chial muscle preparations. The experiments were
performed using combinations of potent inhibitors
and antagonists of inflammatory mediators, includ-
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ing BAY x1005 which is a selective LT synthesis
inhibitor in human bronchi. 17
Materials and methods
Experimental protocol: Human lung tissues were
obtained from patients who had undergone
thoracotomy for lung carcinoma. Subsequent to the
resection of a lung or a lobe, segments of bronchi
were dissected free of parenchymal tissue and placed
in Tyrode’s solution. The preparations were stored at
4C and used within 18 h. Bronchial ring prepara-
tions (2-4 mm of internal diameter) were set up in an
organ bath (initial loads of 2-2.5 g) in Tyrode’s solu-
tion at 37C aerated with 5% CO,. in O,.. The compo-
sition of the Tyrode’s solution was (millimolar con-
centrations): NaCl, 139.2; KCl, 2.7; CaC12, 1.8; MgCl,.,
0.49; NaHCO, 11.9; NaH2PO4, 0.4 and glucose, 5.5;
pH 7.4. Isometric force-displacement transducers
(Narco, F-60) and Linseis physiographs were used to
record the changes in force. The tissues were al-
lowed to equilibrate for 90 min then contracted with
acetylcholine (ACh; 100t.tM) and subsequently
washed until basal tone was re-established. Bron-
chial ring preparations were challenged with differ-
ent dilutions of anti-IgE using either an individual or
cumulative dosing method. In another series of
protocols, different preparations were exposed for 30
min to either: vehicle (control), the H antagonist
chlorpheniramine (Chl; 1 btM), the cyclooxygenase
inhibitor indomethacin (Ind; 3 l.tM), the LT synthesis
inhibitor BAY x1005 (3 l.tM) or a combination of
these drugs at the same concentrations. Other prepa-
rations were treated with the thromboxane (TP)
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receptor antagonist BAY u3405 (0.1 ILtM). At the end
of this incubation, the tissues were challenged with
anti-IgE (dilution 1:1000). Some untreated prepara-
tions were stimulated with anti-IgG (1:1000 of dilu-
tion).
100
8O
Calculation of results: The ACh (100 l.tM) response
and the effect of drugs on the basal tone were
expressed in g. Relaxation was indicated by a nega- o..9. 60 tive symbol (-). Anti-IgE maximal responses are pre-
sented as percent of the initial contraction induced
by ACh. Results are means _+ S.E.M. obtained from
(n) lung samples. Statistical significance was per-
formed using the Student’s t-test and were consid- 40
ered to be significant atp < 0.05.
Drugs: The drugs and their sources were: hista-
mine dihydrochloride, acetylcholine chloride,
chlorpheniramine maleate, and indomethacin (Sigma
Chemical Company, St. Louis, MO, USA); anti-(hu-
man IgE) and anti-(human IgG) (Nordic Immunologi-
cal Laboratories, Tilburg, The Netherlands). BAY
u3405 and BAY x1005 were a gift from Bayer plc UK.
These two latter drugs were diluted in DMSO and
further dilutions were performed in Tyrode’s buffer.
The final dilution of DMSO was less than 1/10000
and did not alter the bronchial resting tone and anti-
IgE response.
Results
Human isolated bronchial muscle preparations
contracted when anti-IgE was added to the tissues
using either a cumulative or individual dosing
method (Fig. 1). The results obtained using both
methods were not significantly different. Anti-IgG
did not produce any contraction of preparations
(n 3). The effects of the different drugs on the
resting tone of human airways are presented in Table
1 and Fig. 2. Ind (3 l.tM) did not significantly alter
the resting tone. BAY x1005 (3 btM) or Chl (1 l.tM)
relaxed the preparations either in the presence or
absence of Ind. The relaxation induced by the com-
bination of Chl/BAY x1005 was not significantly
different from preparations treated only with BAY
x1005. BAY u3405 (0.1 l.tM) also relaxed bronchial
muscle basal tone. The contractions induced by anti-
IgE (1:1000) were significantly enhanced (28%) fol-
lowing Ind (3 t-tM) treatment and in tissues treated
with the combination Ind/Chl. The anti-IgE-
induced contraction after incubation with BAY x1005
was not different from the data obtained following
incubation with BAY xl005/Ind. In contrast, the
response of Chl treated preparations was signifi-
cantly reduced compared with the response
observed in Ind/Chl treated tissues. The anti-IgE-
induced maximal contraction was not modified by
either Chl (1 l.tM), BAY x1005 (3 t.tM) or BAY u3405
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FIG. 1. Anti-lgE-induced contractions in human isolated airways. Bronchial
rings were challenged with different dilutions of anti-lgE using either cumu-
lative (e) or non-cumulative (O) method. Data are presented as percent of
the acetylcholine (ACh; 100 IM) contractions which were 3.36 0.71 g and
2.44 0.47 g for anti-lgE cumulative or non-cumulative curves, respec-
tively. Values are means S.E.M. obtained from five lung samples.
(0.1 l.tM). In contrast, when BAY x1005 was com-
bined with either Ind or Chl, the anti-IgE-induced
contraction was reduced by 37% and 82% when data
were compared with either Ind or Chl treated tissues,
respectively. In addition, in tissues treated with these
three drugs, the anti-IgE responses were completely
blocked. In the absence of Ind, the effects of Chl
were not different from those of BAY x1005.
However, in tissues treated with Ind/Chl the
response was markedly increased when compared
with contractions obtained in tissues treated with
Ind/BAY x1005.
Discussion
Human bronchial ring preparations contracted in a
dose-dependent manner when anti-IgE was added to
the tissues, data which support previous results. TM An
endogenous release of mediators may be involved in
the basal tone of human airways in vitro, since
relaxations were observed in tissues treated with Chl,
BAY x1005 or BAY u3405. The results are consistent
with the relaxations of human airway tone observed
in previous reports.17,19, In tissues treated with either
the TP receptor antagonist BAY u3405, which blocks
the effects of contractile prostanoids, 19 or the antihis-
tamine Chl, there was no alteration in anti-IgE-in-IgE contraction ofhuman airways
Table 1. Effects of drug treatments on basal tone and anti-lgE response in human airways
Treatment No. of lung samples ACh Basal tone Anti-lgE
(n) (g) (g) (%ACh)
Ctrl 18 2.19 + 0.28 0.04 + 0.04 58 +/- 8
BAY x1005 6 2.01 +/- 0.48 -0.14 +/- 0.08 38 +/- 13
Ind 18 1.80 +/- 0.21 0.14 +/- 0.06 81 +/- 6
Ind + BAY x1005 6 1.89 +/- 0.44 -0.12 +/- 0.04 30 +/- 12
Chl 18 2.07 +/- 0.28 -0.23 +/- 0.06 65 +/- 8
Chl + BAY x1005 6 1.46 +/- 0.26 -0.49 +/- 0.18 12 +/- 4
Ind + Chl 18 1.68 +/- 0.28 -0.24 +/- 0.08 90 +/- 8
Ind + Chl + BAY x1005 6 2.09 +/- 0.46 -0.41 +/- 0.13 +/-
BAY u3405 8 2.31 +/- 0.42 -0.18 +/- 0.06* 63 +/- 7
Airway preparations were contracted with acetylcholine (ACh; 100 IM), washed until basal tone was
re-established and incubated (30 min) with either vehicle (Ctrl), BAY x1005 (3 IM), indomethacin
(Ind; 3 M), chlorpheniramine (Chl; IM), BAY u3405 (0.1 IM) or a combination of these drugs.
Effect of drugs on basal tone are presented in g and negative signs indicate relaxation. The maximal
response to anti-lgE (1:1000) is expressed as percent of ACh contractions. Values are means +/-
S.E.M. of n lung samples. "Result different from control (P < 0.05, Student’s t-test). All other
significances are indicated in Figs 2 and 3.
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FIG. 2. Effects of drug treatments on human airways resting tone. Tissues were exposed for 30 min to vehicle (Ctrl), BAY x1005 (3 IM),
indomethacin (Ind; 3M) chlorpheniramine (Chl; IM) or a combination of these drugs at the same concentrations. Responses are expressed
in g. Values are means S.E.M. *Indicates data significantly different from control (Ctrl) and other values significantly different are shown by
horizontal bars (P < 0.05, Student’s t-test).
duced contraction. Ind did not modify resting tone in
human airways
’1 but the contractile response to an-
tigen was enhanced, results similar to those reported
by Adams and Lichtenstein.
22 However, the increase
in contraction observed upon antigen challenge of
human airways in vitro was small (approximately
30%) and in other protocols not observed.1-13 This
slight modulation in human airways is markedly
different from that which was reported for guinea-pig
tracheal preparations23 where potentiation of antigen
response was considerable (2- to 3-fold) subsequent
to the Ind treatment. Undem et al.4 have suggested
that in human bronchial muscle preparations
prostaglandin E,. may regulate the release of hista-
mine from mast cells during antigen challenge.
Therefore, removal of an endogenous inhibitory
cyclooxygenase product may explain the enhanced
contractile response which may be due to the in-
creased quantity of histamine detected. However, in
conditions where only a histamine component re-
mained (Ind/BAY x1005 treated tissues), the re-
sponse to anti-IgE was not significantly altered when
compared with preparations treated with BAY x1005.
Therefore, the increased quantity of histamine may
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FIG. 3. Effects of drug treatments on anti-lgE-induced contraction of human airways. Tissues were exposed for 30 min to vehicle (Ctrl), BAY x1005
(3 M), indomethacin (Ind; 3 iM),chlorpheniramine (Chl; IM) or a combination of these drugs at the same concentrations. The tissues were
contracted with anti-lgE (1 1000). Responses are expressed as percent of acetylcholine (ACh; 100 M). Values are means S.E.M. ACh and
the number of lung samples are presented in Table 1. Indicates data significantly different from control (Ctrl) and other values significantly different
are shown by horizontal bars (P < 0.05, Student’s t-test).
not explain the enhanced contractile response in
tissues treated with Ind. In contrast, tissues treated
with the combination Ind/Chl where the LT compo-
nent was present, the contraction was significantly
enhanced compared with results obtained in Chl-
treated preparations. These latter observations sug-
gest that metabolites of the cyclooxygenase pathway
may modulate the LT-induced contraction. A shunt-
ing of arachidonic acid to metabolites of the
lipoxygenase pathway in the presence of Ind has
been suggested by Undem et al.4, where LTD4 and
EWE were reported to be increased. However, an-
other study17 did not observe an increased produc-
tion of LTE4 during anti-IgE stimulation of human
airway in the presence of Ind. The data presented in
this present report suggest that reduced contraction
in the presence of prostaglandins may be due to
modulation of LT contraction by metabolites of
cyclooxygenase pathway rather than alteration in
histamine release. Dahln et al. TM have recently
demonstrated that the contraction provoked by IgE-
mediated stimulation of human airways could be
antagonized by treatment of the tissues with an LT
antagonist (ICI 198,615) or an inhibitor of LT
biosynthesis (Piriprost). However, a number of re-
ports using respiratory tissues from different animal
species suggested that inhibitors of the 5-LO pathway
alone were not effective. Only under specific experi-
mental conditions, namely in the presence of Ind and
an antihistamine, were 5-LO inhibitors effective in
blocking the antigen induced contraction.a In
addition, Muccitelli et al. demonstrated that in hu-
man bronchial muscle LT antagonists were more
effective in blocking the antigen challenge in human
bronchial muscles pretreated with meclofenamate
and an antihistamine than in untreated tissues. The
present data define the pretreatments necessary to
observe the effects of 5-LO inhibitors in human
airways challenged with anti-IgE. BAY x1005 has
been previously shown to inhibit the EWE release
induced by anti-IgE on human airways.
1 In the
present report, the data show that BAY x1005 did not
significantly inhibit the contractions induced by
anti-IgE. However, the LT-synthesis inhibitor
markedly decreased the contractions induced by
anti-IgE when airways were also treated with either
Ind, Chl or the combination Ind/Chl. These results
indirectly suggest that the other inflammatory
mediators which are released during anti-IgE chal-
lenge cause a contraction of the bronchial
muscle and may mask the evaluation of the LT
component. Furthermore, in the absence of
prostanoids, the LT contraction is the major compo-
nent of the anti-IgE contraction.
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